Morgan Stanley began buying shares of Catalyst Pharmaceuticals, which falls under the purview of SEC disclosure requirements.

The entities involved

• Catalyst Pharmaceuticals →

  company in Coral Gables, United States

  Nothing else this week.

• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12
• Morgan Stanley →

  U.S. investment bank

  • Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24

Related events

• Institutional investors are actively buying and selling SoFi Technologies, Inc. stock, with disclosures being made to the SEC.Aug 31
• Allient stock traded on NASDAQ and filed required disclosures with the SEC on August 18, 2026.Aug 18
• Shell disclosed its holdings to the SEC on September 8, 2026.Sep 9
• Newell Brands stock trades on the electronic exchange and discloses insider transactions with the SEC.Aug 27
• HCW Biologics Inc. filed disclosures with the SEC and its shares are listed on Nasdaq.Jun 27